Data integrity deficiencies january, 2016 the tabulation on pages 454 include full text of data integrity deficiencies identified in fda drug gmp warning letters issued in calendar year 2015. Fda data integrity findings continue at indian firms. Clearance of the warning letter may require another inspection, sun pharmas shanghvi said on the call. Read more about sun pharma says usfda issues at halol over, two specialty drugs may get nod on business standard. Sun pharmas stock fell as much as 3 percent to 636. The fda has issued a warning letter to sun pharmaceutical for its. In december 2016 the fda sent sun a warning letter about nine violations at its manufacturing plant in halol. When the us fda finds that a firm has significantly violated fda regulations e. By 2007, this stake has reached 75% on a diluted basis. Get latest sun pharma newsupdates and resultsanalysis. From september 819, 2014, investigators from the u.
Press release sun pharma receives warning letter for halol. Ranbaxys stronghold in the fast growing emerging markets 50% of ranbaxys sales will complement suns presence in this space. View strides shasun limiteds fda inspection, warning letter, form 483 observation details related to gmp quality systems on. While the plant was served warning letter by us regulator in december 2015, product approvals were frozen in september 2014. Indian pharma under pressure with us fda warning letters. Sun says halol plant cited again by the fda fiercepharma.
Our bureau mumbai updated on march 12, 2018 published on may 21, 2014. Sun pharma gets us fda warning for manufacturing lapses. Says receives warning letter from fda over insufficient data on 29 of its active pharmaceutical ingredients api. Sun pharma receives warning letter for halol facility. Last december, the us drug regulatory agency had issued a warning letter to the same site.
Article cadila healthcare gets fda warning, shares plunge 17%. Top 10 fda warning letter findings for finished pharmaceuticals in 2015. Sun pharma shares fall 7% after fda warning financial times. Sun pharma receives warning letter for halol facility mumbai, december 19, 2015. Sun pharmaranbaxy deal gets noobjection from bse, nse. The pharma letter provides subscribers with daily, uptodate news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field. Food and drug administration fda inspected your pharmaceutical manufacturing facility, sun. Indias largest drug maker sun pharma has received a warning letter from the us fda for manufacturing lapses at its facility in halol. Mumbai the us fda has begun its inspection at sun pharmas halol manufacturing facility, considered to be the most crucial for the company, according to three industry sources. Sun pharma says usfda issues at halol over, two specialty. The ranbaxy acquisition will also drag margins initially though it is expected to bring benefits of scalability in the long run. Fda warning not heeded by wockhardt wockhardts problems detailed in the july 20 warning letter were based on a sixday inspection of its biotech park facility in waluj, india the previous march ibid. The inspection lasted 12 days from the 8 th september to the 19 th september, 2014 while the warning letter was issued only in december, 2015 a complete year later as there were.
On the 17dec15 thursday, the us fda issued a warning letter to sun pharmaceuticals. Sun pharma and ranbaxy to merge, create giant pharma co we had managed to get our hands on the warning letter issued by us fda late last year. The fda in its letter dated january 15, 2017 to fleming laboratories, a pharma company in the business of manufacturing and supply of high quality generic active pharmaceutical ingredients apis to the global pharmaceutical industry observed that it has completed an evaluation of the firms corrective actions in response to its warning letter. Gmp drug warning letters issued in calendar year 2015 data. Sun pharmaceuticals confirmed the receipt of the us fda warning letter on the 19dec15 saturday after the markets had closed for the week. Sun pharma hit with warning letter over data issues. In may, sun pharmas another manufacturing facility in karkhadi, also in gujarat, had received a warning letter from the us fda after investigators identified violations of current good manufacturing practice and regulations for finished pharmaceuticals. During 2015, us fda issued 17 warning letter against 7 in the 2014 and major companies like dr reddys laboratories, cadila healthcare, sun pharmaceutical, unimark remedies, micro laboratories were recipient of warning letters or import alerts during 2015. Briefzhejiang hisun pharma receives warning from u.
Indias largest drugmaker sun pharma gets warning letter. Sun pharma gets warning letter from usfda the hindu. Fda finds incomplete lab records at sun pharma plant. Us fda descends on sun pharmas halol unit business.
A year after facing insider trading claims, sun pharma now must fight charges it fired two former employees for refusing to market its meds offlabel. The violation, such as poor manufacturing practices, problems with claims for what a product can do, or. If you need help accessing information in different file formats, see instructions for downloading. Us fda conducted its first inspection of the facility in 2014 and another in december 2015. Sun pharma subsidiary receives fda warning letter 1 min read. The warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply. The action followed over 20 observations that were detected in 2014 as part of us fdas routine inspections. Shanghvi said the drug maker is giving top priority to bring back halol unit under compliance. The warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply about 40 per cent of the medicines sold in the united. Tell a friend print home sun pharma receives warning letter for halol facility. By pharma news dcat publisher january 5, 2016 the us food and drug administration fda has issued a warning letter to sun pharmaceutical industries ltd. Sun pharma gets warning letter from usfda for key facility.
The board of directors of sun pharmaceutical industries ltd at its meeting held allotted 18,71,77,232 6% cumulative redeemable preference shares of re 1 each as bonus shares in the ratio of 4. The letter provides eyeopening insights into the integrity lapses and efforts to cover them up that fda has been finding in india. Sun pharma gets usfda warning letter on halol facility. The fda said in its warning letter from earlier this month, which comes as sun has also been issued an import alert over cgmp issues, that sun is missing fundamental raw data and information necessary to document its analyses. Sun pharma gets warning letter from usfda newsgram. Article sun pharma fy 2016 1stqtr hit by ranbaxy integration and other costs. Also get sun pharma sharestock detailed information on sun pharma along with top stories and articles on sun pharma during last 6 months. Food and drug administration has pulled up a former sun pharmaceutical sun. Links to the warning letter on the fda website are included as well as information regarding imposition of import alerts posted on the fda website. Fda warns former sun pharma us drug factory over quality. When contacted on phone, sun pharma spokesperson declined to comment. Dilip shangvi, managing director, expressed consternation that the warning letter, received on friday, had been sent so long after the september 2014 inspection, as he said sun had been working. The issues first crept up in 2014, and then the plant in 2015 was savaged in a warning letter that found a host of problems including data integrity concerns.
Progress at suns halol, india, plant tarnished by new fda. Article sun pharma finally completes ranbaxy acquisition. The letter was in relation to the inspection performed from 819 september, 2014, at the pharmaceutical manufacturing facility, halolbaroda highway, halol, gujarat. Draft letter of offer september 15, 2015 for our equity shareholders only sun pharma advanced research company limited our company was incorporated on march 1, 2006 as sun pharma advanced research company limited under the provisions of the companies act, 1956 having registration number 047837 of 2006 with the registrar of companies, ahmedabad, gujarat.
Press release sun pharma receives warning letter for halol facility. Ns drug factory for knowingly releasing 27 lots of. The warning letter even led the fda in 2015 to revoke approval of a new epilepsy drug developed by biotech sparc for sun. Warning letter for halol facility call transcript 06. Sun pharma warns new normal will push down its sales. Fda slaps sun pharma with warning letter on indian plant. Sun house, 201 b1, western express highway, goregaon e, mumbai 400063 for further updates and specific queries, please visit. Us fda warns sun pharma for violating manufacturing. Tracking the sun pharma halol plant us fda inspection. Fda warning letter hits sun pharma for hiding batch failures.
Food and drug administration fda inspected your pharmaceutical manufacturing facility, sun pharmaceutical industries ltd. In addition, sun seems to have taken on a practice whereby it unofficially tests samples and then discards the results while reporting results from other tests. Us regulator warns sun pharma for violating manufacturing. Sun pharma has received a warning letter from the us drug regulator usfda over violation of manufacturing norms in its facility at halol in gujarat. The warning letter from the usfda will add to the troubles being faced by sun pharma, which has also been weighed down by the integration process with ranbaxy laboratories. View sun pharmaceutical industries limiteds fda inspection, warning letter, form 483 observation details related to gmp quality systems on. Sun pharma was earlier issued a warning letter by the usfda for its halol facility in december 2015. Sun pharmaceuticals factory in halol, in the western indian state of gujarat, received a warning letter from the fda, the latest setback for indias pharmaceutical companies. Sun pharma says it sought reinspection of its halol.
580 598 1487 1563 182 1574 1436 779 274 584 139 479 1311 1299 268 1337 503 24 287 1404 737 691 677 282 1003 332 1042 1032 1594 1432 247 554 453 590 1415 927 674 524 1043 908 258